1.7.13-Bill Jackson Ph.D. recently presented aptamer information and data at the recent American Society for Cell Biology meeting in San Francisco December 16, 2012.  This presentation was recorded and is now available as a video on YouTube.  Preliminary aptamer data presented included biosensor and lateral flow assays among others.

11.27.12 To improve communication between our scientists and researchers involved in custom aptamer development Base Pair Biotechnologies has initiated an innovative and convenient cloud-based team collaboration and project management application tool to effectively manage projects and work in one central place. Once invited to a custom AptaTracker™ project our scientists will update the status of […]

11.5.12 Base Pair Biotechnologies Scientist Mark Morris, Ph.D. presented two posters at the recent Southwest Regional Meeting of the American Chemical Society in Baton Rouge, LA.  “Binding analytics of DNA aptamers to small molecules determined by microscale thermophoresis (MST)” co authored by NanoTemper Technologies GmbH and 2bind GmbH and “Borotin TM”: A dual function boronate-biotin molecular probe for measuring glycation/glycosylation of proteins”. […]

10.29.12 BCC Research has recently released its updated market report  Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets written by George W. “Bill” Jackson, PhD., Base Pair Biotechnologies Founder and Chief Scientist.  This report includes an overview of the specific applications for nucleic acid aptamers for therapeutic and diagnostic purposes, with a focus on applications judged […]

10.29.12 Base Pair Biotechnologies, Inc. is collaborating with Vista Therapeutics, Inc. to create a powerful collection of Nanowire-Aptamer probes whose sensitivity and ease of use is currently unmatched.  Using Vista’s proprietary ‘Universal Linker’ system, aptamers can be readily attached to Vista’s nanowires without modification.  Vista has demonstrated that Base Pair’s aptamers can be used quite successfully with nanowires as […]

9.21.12-Base Pair Biotechnologies Founder & Chief Scientist, Dr. Bill Jackson will direct a new 1 year SBIR grant from the National Institute of Environmental Health Sciences (NIEHS) entitled, “Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure“. Under the contract, which is formally placed with Base Pair’s parent company, BioTex, Inc., novel aptamers will be […]

9.17.12-Base Pair Founder & Chief Scientist, Dr. Bill Jackson will direct a new 2 year contract from the National Cancer Institute entitled, “Development of Alternative Affinity Capture Reagents for Cancer Proteomics Research“.  Under the contract which is formally placed with Base Pair’s parent company, BioTex, Inc., novel aptamers to at least 75 selected cancer biomarker […]

9.6.12-Base Pair Biotechnologies has recently been approved by the U.S. Drug Enforcement Administration for research use of controlled substances.  Clients are taking advantage of our ability to now utilize illicit drugs as targets for aptamer selection and incorporation in novel assays.

7.30.12-Bill Jackson PhD, CSO and founder of Base Pair has released an Application Note describing funded work done in 2009 with small molecule specific aptamers and FRET assays.  There is a continuing need for more reliable, more sensitive and more economical methods in “field forward”and point-of-care applications. Because of their stability, low cost of synthesis, […]

7.24.12-We have published a new Tech Note exploring Microscale Thermophoresis (MST) for characterizing the aptamer:target dissociation constant (Kd) of our small molecule specific aptamers. Our discovery services include validation of aptamer binding by Kd before delivery of aptamer materials to the customer for further testing. Analytical methods such as Surface Plasmon Resonance (SPR) and Biolayer […]